“I am a world-class alcoholic,” growls Nick Offerman’s Eugene O’Neill. “A tragedy magnet, and by all accounts, the last person on Earth you’d want as your birth doula.” “If someone shushes you, don’t ...
This June has been nothing more than Hunter Goodman proving he's the future of the Colorado Rockies franchise with his continuous power at the plate. As June nears its end, the Colorado Rockies find ...
Indianapolis-based Eli Lilly and Company gave an unidentified 79-year-old man exclusive access to its experimental obesity and diabetes drug, according to reporting by the life sciences media ...
When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the ...
Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
Let's start by looking at how this recent slew of acquisitions will reshape Lilly's pipeline. Lilly acquired Kelonia Therapeutics to deepen its position in the oncology cell therapy space, which it ...
Saul Goodman must have gotten off on parole, as Bob Odenkirk suited up as the criminal lawyer for a “Know Your Rights” PSA celebrating America’s 250th birthday. “Hi, I’m Saul Goodman. Did you know you ...
Eli Lilly has signed a heavily backloaded agreement to license a gamma-secretase modulator treatment for Alzheimer's disease from AlzeCure Pharma for up to $1 billion biobucks. Lilly is obtaining the ...
It’s a sign of the times that this year’s American Diabetes Association (ADA) Scientific Sessions meeting in New Orleans featured more chatter on obesity drugs and pipeline programs than those ...
The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens. By Rebecca Robbins See more of our coverage in ...
LimmaTech's lead program targets S. aureus, a major cause of surgical-site infections Vaccine Company acquisition includes experimental vaccine for Epstein-Barr virus Curevo is developing shingles ...
Eli Lilly trades at $948.45 as of writing. Our 24/7 Wall St. price target is $1,085 over the next 12 months, implying roughly 14.3% upside. The recommendation is buy with a confidence level of 70%.
Getting your Trinity Audio player ready... Happy for Drew Goodman and Hunter Goodman as the Rockies start winning The two people I am happiest for this Rockies season are Drew Goodman and Hunter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results